Eurycoma Longifolia Extract is a phytopharmaceutical preparation derived from plant source material through extraction or expression processes that concentrate pharmacologically active secondary metabolites. The chemical fingerprint of Eurycoma Longifolia Extract varies with botanical species, chemotype, geographic origin, and harvest season, necessitating validated HPLC-based analytical methods capable of identity confirmation and quantification of characteristic marker compounds. PDE derivation for botanical preparations must address the complexity of multiple co-occurring active and potentially toxic constituents, often drawing on the toxicological profile of key individual chemical entities as surrogates for the whole extract.
The pharmacologically-based OEL approach is used for Eurycoma Longifolia Extract when its receptor-mediated pharmacodynamic activity in humans produces the most sensitive adverse effect at doses below the NOAEL from general organ toxicity studies.
